Discover how a select group of exceptional young scientists from South Africa will engage with Nobel Laureates at the ...

Home > Press release: Still Open for Media: Accreditation for ... Contact Communications Wolfgang Haaß +49 8382 / 27731-26 [email protected] ...

From Sunday, 29 June, to Friday, 4 July, they will encounter the next generation of scientific talent in Lindau – over 600 young researchers representing more than 80 nationalities. This year ...

Seal Beach officials are raising parking rates across all beach parking lots while simultaneously opening the lots for public ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

The U.S. Food and Drug Administration said on Wednesday it has approved the expanded use of Merck's cancer drug to treat two ...

For a century and a half, the Hospital for Sick Children (SickKids) has been there when the most vulnerable in our society ...

Every year, Nobel Laureates and excellent young researchers from all over the world come together in Lindau to network and debate on scientific findings. Since 1951, Laureates in chemistry, physics ...

Tuberous sclerosis complex and von Hippel–Lindau disease are distinct autosomal dominant tumor suppressor syndromes that can exhibit similar renal phenotypes and seem to share some signaling ...

Merck beats Q1 2025 estimates despite Gardasil sales drop, driven by Vaxneuvance, Winrevair & Welireg. Click here to find out ...

His mom, Marthe Cohn, had been living in the U.S. since 1956, shortly after meeting his father, an American. She worked as a ...

Welireg is currently approved in the United States for patients with advanced renal cell carcinoma andsome von Hippel-Lindau disease-associated tumors. Merck's phase III ovarian cancer study on a ...